<?xml version="1.0" encoding="UTF-8"?>
<p id="Par19">Transfusion of convalescent plasma from recovered patient donors has proved to be effective in treating severe and critically ill COVID-19 patients, without any severe adverse effects (Duan et al. 
 <xref ref-type="bibr" rid="CR2">2020</xref>). However, convalescent plasma therapy requires further validation with large-scale randomized trials.
</p>
